Ambr 250 High Throughput Bioreactor System
Closed Special Notice Posted
A newer solicitation was posted. See the latest solicitation from .
- Solicitation number
- PANDHA25P0000-007301
- Agency
- Defense Health Agency Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Silver Spring, Maryland 20910, United States
- Points of contact
-
- Brenda Mena brenda.i.mena.civ@health.mil (301) 619-1013
- Sharew Hailu sharew.hailu.civ@health.mil (301) 619-9201
Notice details come from SAM.gov. Updated .
About this opportunity
The United States Army Medical Research Acquisition Activity (USAMRAA), an agency within the Defense Health Agency, has issued a Special Notice of Intent to Award a Sole Source contract to Sartorius Stedim North America, Inc. The notice concerns the procurement of an Ambr 250 High Throughput Bioreactor System for the Pilot Bioproduction Facility (PBF) at the Walter Reed Army Institute of Research (WRAIR). The bioreactor system is specifically intended to support the development of vaccines and biologics for military-relevant infectious disease threats. This procurement is being pursued under FAR 13.5 as a sole source acquisition, targeting the enhancement of monoclonal antibody production capabilities. The notice was published on March 11, 2025, with a response deadline of March 27, 2025.
The primary objective of this procurement is to acquire a high-throughput bioreactor system that enables rapid development of scalable fermentation processes through multiple parallel bioreactors and automated liquid handling. The contract will consist of one base year, including delivery, equipment installation, and support, followed by three optional support periods. Interested contractors are invited to submit capability information in writing to Ms. Brenda Mena by 2:00 p.m. EST on March 27, 2025, though the government retains sole discretion to proceed with the sole source procurement regardless of responses received. The system must meet specific minimum essential characteristics, including processing up to 12 parallel cultures, supporting both mammalian and microbial cell cultures, and complying with 21 CFR Part 11 requirements. Potential contractors must demonstrate their ability to provide the required capabilities, with the ultimate goal of supporting the PBF's research and development of critical biologics and therapeutics for military applications.
Notice text
Synopses – Notice of Intent to Award Sole Source to Sartorius Stedim NA, Inc.
Date: Tuesday, 11 March 2025
Year: FY2025
Contracting Office Zip Code: 21702-9232
Contracting Office Address – USA Medical Research Acquisition Activity, 808 Schreider Street, Fort Detrick, MD 21702-5014
Subject: Notice of Intent to Sole Source Award
Ambr 250 High Throughput Bioreactor System for the Pilot Bioproduction Facility (PBF) at The Walter Reed Army Institute of Research (WRAIR)
The United State Army Medical Research Acquisition activity intends to negotiate on a sole source basis, IWA FAR 13.5, with Sartorius Stedim North America, Inc.
The Pilot Bioproduction Facility (PBF) at the Walter Reed Army Institute of Research (WRAIR) specializes in the development of vaccines and biologics for military-relevant infectious disease threats.
The purpose of this requirement is to have the PBF Manufacturing Science and Technology team to develop and maintain a Monoclonal Antibody (mAb) production capability for the development of biologics and therapeutics. A high throughput bioreactor is required for rapid development of scalable fermentation processes using multiple parallel bioreactors and a fully automated liquid handling platform, enabling researchers to test numerous conditions simultaneously, thereby accelerating the development process. This technology has been globally adopted for various bioprocess development and optimization applications.
Objectives:
This follow-on requirement is for a Brand Name or Equivalent of Ambr 250 High Throughput Bioreactor Systems and meets the Statement of Work and the Minimum Essential Characteristics (MECs). The period of performance will be one base year to include delivery, equipment, installation and one year support plus three option periods for support.
Support includes maintenance by OEM licensed and certified technicians.
THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTATIONS. Responsible, interested parties may identify their interest by submitting capability information, in writing, by 2:00 p.m. EST, Thursday, 27 March 2025 to Ms. Brenda Mena at brenda.i.mena.civ@health.mil . Supporting evidence must be furnished in sufficient detail to demonstrate the firm’s ability to provide the stated capability.
Responses will be evaluated; however, a determination by the Government not to compete the proposed procurement based upon responses to this notice is solely within the discretion of the Government. If no responses are received, USAMRAA will proceed with the sole source contract.
Attachments
| File | Type | Posted |
|---|---|---|
| SOW - Ambr 250 Bioreactor system.pdf | ||
| -MEC - Ambr 250 Bioreactor system.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| BRAND NAME Ambr 250 High Throughput bioreactor for WRAIR | Solicitation | |
| Ambr 250 High Throughput Bioreactor | Solicitation | |
| Ambr 250 High Throughput Bioreactor System | Pre-Solicitation | |
| Ambr 250 High Throughput Bioreactor System | Special Notice | |
| Ambr 250 High Throughput Bioreactor System | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity